230 related articles for article (PubMed ID: 27767105)
1. Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma.
Zhang J; Liu Z; Lian Z; Liao R; Chen Y; Qin Y; Wang J; Jiang Q; Wang X; Gong J
Sci Rep; 2016 Oct; 6():35784. PubMed ID: 27767105
[TBL] [Abstract][Full Text] [Related]
2. Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition.
Zhu W; Zhao Y; Zhou J; Wang X; Pan Q; Zhang N; Wang L; Wang M; Zhan D; Liu Z; He X; Ma D; Liu S; Wang L
J Hematol Oncol; 2016 Nov; 9(1):127. PubMed ID: 27884159
[TBL] [Abstract][Full Text] [Related]
3. [Monoacylglycerol lipase high expression as an independent indicator of survival for patients with hepatocellular carcinoma].
Liu Y; Yang XL; Gong JP; Zhang JY
Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):760-765. PubMed ID: 31734989
[No Abstract] [Full Text] [Related]
4. MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence.
Xia H; Kong SN; Chen J; Shi M; Sekar K; Seshachalam VP; Rajasekaran M; Goh BKP; Ooi LL; Hui KM
Cancer Lett; 2016 Dec; 383(1):85-93. PubMed ID: 27693640
[TBL] [Abstract][Full Text] [Related]
5. Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer.
Ye L; Zhang B; Seviour EG; Tao KX; Liu XH; Ling Y; Chen JY; Wang GB
Cancer Lett; 2011 Aug; 307(1):6-17. PubMed ID: 21543155
[TBL] [Abstract][Full Text] [Related]
6. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.
Mok WC; Wasser S; Tan T; Lim SG
World J Gastroenterol; 2012 Jul; 18(27):3527-36. PubMed ID: 22826617
[TBL] [Abstract][Full Text] [Related]
8. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
Lee N; Kwon JH; Kim YB; Kim SH; Park SJ; Xu W; Jung HY; Kim KT; Wang HJ; Choi KY
Oncotarget; 2015 Oct; 6(30):30130-48. PubMed ID: 26375549
[TBL] [Abstract][Full Text] [Related]
10. Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer.
Li X; Gao S; Li W; Liu Z; Shi Z; Qiu C; Jiang J
J Obstet Gynaecol Res; 2019 Oct; 45(10):2043-2054. PubMed ID: 31357249
[TBL] [Abstract][Full Text] [Related]
11. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
12. [Effect of monoacylglycerol lipase with proliferation of MHCC97H human liver cancer cells in vivo].
Zhu WP; He XG; Zhao YM; Pan Q; Zhang N; Zhou JM; Wang LR; Wang M; Liu ZY; Zhu HX; Wang L
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):516-520. PubMed ID: 31357777
[No Abstract] [Full Text] [Related]
13. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.
Muldoon PP; Chen J; Harenza JL; Abdullah RA; Sim-Selley LJ; Cravatt BF; Miles MF; Chen X; Lichtman AH; Damaj MI
Br J Pharmacol; 2015 Feb; 172(3):869-82. PubMed ID: 25258021
[TBL] [Abstract][Full Text] [Related]
15. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
[TBL] [Abstract][Full Text] [Related]
16. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L
Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005
[TBL] [Abstract][Full Text] [Related]
17. The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity.
Gu D; Jin H; Jin G; Wang C; Wang N; Hu F; Luo Q; Chu W; Yao M; Qin W
Cancer Lett; 2016 Aug; 379(1):107-16. PubMed ID: 27241665
[TBL] [Abstract][Full Text] [Related]
18. The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.
Sakin YS; Dogrul A; Ilkaya F; Seyrek M; Ulas UH; Gulsen M; Bagci S
Neurogastroenterol Motil; 2015 Jul; 27(7):936-44. PubMed ID: 25869205
[TBL] [Abstract][Full Text] [Related]
19. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.
Ma X; Guo P; Qiu Y; Mu K; Zhu L; Zhao W; Li T; Han L
Oncotarget; 2016 Jun; 7(24):36185-36197. PubMed ID: 27167192
[TBL] [Abstract][Full Text] [Related]
20. Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.
Wang C; Jin G; Jin H; Wang N; Luo Q; Zhang Y; Gao D; Jiang K; Gu D; Shen Q; Huo X; Hu F; Ge T; Zhao F; Chu W; Shu H; Yao M; Cong W; Qin W
Oncotarget; 2015 Feb; 6(5):2903-16. PubMed ID: 25609201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
